Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Tempest Therapeutics, Inc. (TPST) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Tempest Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1544227.
Total stock buying since 2014: $22,803,203.
Total stock sales since 2014: $967,186.
Total stock option exercises since 2014: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 231,482 | $500,001 | 0 | $0 | 0 | $0 |
| 2024 | 39,672 | $83,801 | 787,999 | $967,186 | 0 | $0 |
| 2022 | 2,122,344 | $5,017,727 | 0 | $0 | 0 | $0 |
| 2016 | 1,907,212 | $14,641,337 | 0 | $0 | 0 | $0 |
| 2015 | 85,550 | $2,528,108 | 0 | $0 | 0 | $0 |
| 2014 | 1,000 | $32,229 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2026-03 | 231,482 | $500,001 | 0 | $0 | 0 | $0 |
| 2024-08 | 0 | $0 | 787,999 | $967,186 | 0 | $0 |
| 2024-07 | 39,672 | $83,801 | 0 | $0 | 0 | $0 |
| 2022-04 | 2,118,644 | $4,999,999 | 0 | $0 | 0 | $0 |
| 2022-01 | 3,700 | $17,728 | 0 | $0 | 0 | $0 |
| 2016-06 | 850,000 | $5,950,000 | 0 | $0 | 0 | $0 |
| 2016-05 | 255,090 | $1,910,617 | 0 | $0 | 0 | $0 |
| 2016-03 | 802,122 | $6,780,720 | 0 | $0 | 0 | $0 |
| 2015-10 | 8,250 | $88,706 | 0 | $0 | 0 | $0 |
| 2015-09 | 9,100 | $153,388 | 0 | $0 | 0 | $0 |
| 2015-08 | 300 | $5,568 | 0 | $0 | 0 | $0 |
| 2015-05 | 20,300 | $163,106 | 0 | $0 | 0 | $0 |
| 2015-04 | 12,600 | $367,340 | 0 | $0 | 0 | $0 |
| 2015-01 | 35,000 | $1,750,000 | 0 | $0 | 0 | $0 |
| 2014-04 | 1,000 | $32,229 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-03-24 | Angel Matthew (CEO and President) | Buy | 231,482 | 2.16 | 500,001 |
| 2024-08-12 | Versant Side Fund Iv, L.p. | Sale | 387,999 | 1.10 | 427,186 |
| 2024-08-08 | Versant Side Fund Iv, L.p. | Sale | 400,000 | 1.35 | 540,000 |
| 2024-07-03 | Brady Stephen R (President and CEO) | Buy | 35,000 | 2.11 | 73,850 |
| 2024-07-02 | Whiting Samuel (Chief Medical Officer) | Buy | 4,672 | 2.13 | 9,951 |
| 2022-04-29 | Woiwode Thomas (Director) | Buy | 2,118,644 | 2.36 | 4,999,999 |
| 2022-01-07 | Dubensky Thomas W. (President) | Buy | 2,000 | 4.78 | 9,560 |
| 2022-01-06 | Whiting Samuel (Chief Medical Officer) | Buy | 1,700 | 4.80 | 8,168 |
| 2016-06-01 | Dipp Michelle (Chief Executive Officer) | Buy | 425,000 | 7.00 | 2,975,000 |
| 2016-06-01 | Aldrich Richard | Buy | 425,000 | 7.00 | 2,975,000 |
| 2016-05-18 | Dipp Michelle (Chief Executive Officer) | Buy | 20,000 | 7.86 | 157,200 |
| 2016-05-18 | Aldrich Richard | Buy | 20,000 | 7.86 | 157,200 |
| 2016-05-17 | Dipp Michelle (Chief Executive Officer) | Buy | 20,000 | 7.56 | 151,200 |
| 2016-05-17 | Aldrich Richard | Buy | 20,000 | 7.56 | 151,200 |
| 2016-05-16 | Dipp Michelle (Chief Executive Officer) | Buy | 20,000 | 7.69 | 153,800 |
| 2016-05-13 | Dipp Michelle (Chief Executive Officer) | Buy | 16,295 | 7.06 | 115,042 |
| 2016-05-13 | Aldrich Richard | Buy | 16,295 | 7.06 | 115,042 |
| 2016-05-12 | Dipp Michelle (Chief Executive Officer) | Buy | 19,800 | 6.92 | 137,115 |
| 2016-05-12 | Aldrich Richard | Buy | 19,800 | 6.92 | 137,115 |
| 2016-05-11 | Dipp Michelle (Chief Executive Officer) | Buy | 20,000 | 7.64 | 152,800 |
| 2016-05-11 | Aldrich Richard | Buy | 20,000 | 7.64 | 152,800 |
| 2016-05-10 | Chapman Paul W.d. (Chief Operating Officer) | Buy | 3,100 | 7.37 | 22,847 |
| 2016-05-10 | Dipp Michelle (Chief Executive Officer) | Buy | 19,900 | 7.72 | 153,628 |
| 2016-05-10 | Aldrich Richard | Buy | 19,900 | 7.72 | 153,628 |
| 2016-03-24 | Dipp Michelle (Chief Executive Officer) | Buy | 30,000 | 9.23 | 276,900 |
| 2016-03-24 | Aldrich Richard | Buy | 30,000 | 9.23 | 276,900 |
| 2016-03-23 | Dipp Michelle (Chief Executive Officer) | Buy | 29,800 | 9.88 | 294,453 |
| 2016-03-23 | Aldrich Richard | Buy | 29,800 | 9.88 | 294,453 |
| 2016-03-22 | Dipp Michelle (Chief Executive Officer) | Buy | 29,800 | 10.53 | 313,913 |
| 2016-03-22 | Aldrich Richard | Buy | 29,800 | 10.53 | 313,913 |
| 2016-03-21 | Dipp Michelle (Chief Executive Officer) | Buy | 30,000 | 10.11 | 303,360 |
| 2016-03-21 | Aldrich Richard | Buy | 30,000 | 10.11 | 303,360 |
| 2016-03-18 | Dipp Michelle (Chief Executive Officer) | Buy | 29,900 | 8.72 | 260,757 |
| 2016-03-18 | Aldrich Richard | Buy | 29,900 | 8.72 | 260,757 |
| 2016-03-17 | Dipp Michelle (Chief Executive Officer) | Buy | 29,800 | 7.79 | 232,231 |
| 2016-03-17 | Aldrich Richard | Buy | 29,800 | 7.79 | 232,231 |
| 2016-03-16 | Dipp Michelle (Chief Executive Officer) | Buy | 29,529 | 7.86 | 232,038 |
| 2016-03-16 | Aldrich Richard | Buy | 29,529 | 7.86 | 232,038 |
| 2016-03-15 | Dipp Michelle (Chief Executive Officer) | Buy | 29,500 | 8.12 | 239,628 |
| 2016-03-15 | Aldrich Richard | Buy | 29,500 | 8.12 | 239,628 |
| 2016-03-14 | Dipp Michelle (Chief Executive Officer) | Buy | 30,000 | 8.05 | 241,590 |
| 2016-03-14 | Aldrich Richard | Buy | 30,000 | 8.05 | 241,590 |
| 2016-03-11 | Dipp Michelle (Chief Executive Officer) | Buy | 132,732 | 7.50 | 995,490 |
| 2016-03-11 | Aldrich Richard | Buy | 132,732 | 7.50 | 995,490 |
| 2015-10-05 | Young Jeffrey E (Chief Financial Officer) | Buy | 3,450 | 10.70 | 36,915 |
| 2015-10-05 | Kozin Marc D | Buy | 4,800 | 10.79 | 51,791 |
| 2015-09-09 | Fisher Mary | Buy | 6,100 | 16.49 | 100,588 |
| 2015-09-08 | Kozin Marc D | Buy | 3,000 | 17.60 | 52,800 |
| 2015-08-24 | Dipp Michelle (Chief Executive Officer) | Buy | 300 | 18.56 | 5,568 |
| 2015-05-26 | Dipp Michelle (Chief Executive Officer) | Buy | 300 | 31.02 | 9,306 |
| 2015-05-16 | Aldrich Richard | Buy | 20,000 | 7.69 | 153,800 |
| 2015-04-09 | Mcneely Theresa (EVP, Chief Comm. Officer) | Buy | 226 | 29.68 | 6,707 |
| 2015-04-09 | Tzianabos Arthur (President and CSO) | Buy | 225 | 28.77 | 6,473 |
| 2015-04-08 | Mcneely Theresa (EVP, Chief Comm. Officer) | Buy | 174 | 28.79 | 5,009 |
| 2015-04-08 | Tzianabos Arthur (President and CSO) | Buy | 175 | 28.04 | 4,907 |
| 2015-04-08 | Malley Thomas | Buy | 5,000 | 28.50 | 142,500 |
| 2015-04-08 | Young Jeffrey E (Chief Financial Officer) | Buy | 300 | 29.93 | 8,979 |
| 2015-04-08 | Kozin Marc D | Buy | 3,000 | 28.45 | 85,350 |
| 2015-04-08 | Aldrich Richard | Buy | 2,500 | 29.97 | 74,925 |
| 2015-04-02 | Dipp Michelle (Chief Executive Officer) | Buy | 1,000 | 32.49 | 32,490 |
| 2015-01-13 | Malley Thomas | Buy | 35,000 | 50.00 | 1,750,000 |
| 2014-04-10 | Harding David (Chief Commercial Officer) | Buy | 1,000 | 32.23 | 32,229 |
Insider trading activities including stock purchases, stock sales, and option exercises of TPST listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Tempest Therapeutics, Inc. (symbol TPST, CIK number 1544227) see the Securities and Exchange Commission (SEC) website.